Study ID: TVP - 1012/135 Open Label

Study Title

Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease Patients

Teva Identifier

TVP - 1012/135 Open Label

ClinicalTrials.gov Identifier

NCT00203164

Study Status

Completed

Trial Condition(s)

Parkinson's Disease

Interventions

Drug: rasagiline mesylate

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

neurology icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

30 Years and older

Trial Duration

05/01/2002 - 09/01/2006

Phase

Phase 3

Study Type

Interventional